Tuesday 3 December 2019

MRG November Publications

Featuring Tolergenic dendritic cells, MRI and rituximab for JIA patients.

Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
Spiering R, Jansen MAA, Wood MJ, Fath AA, Eltherington O, Anderson AE, Pratt AG, van Eden W, Isaacs JD, Broere F, Hilkens CMU.
J Transl Med. 2019 Nov 14;17(1):375. doi: 10.1186/s12967-019-2128-4.
PMID: 31727095 [PubMed - in process] Free Article
Similar articles 

Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis?
Bennett JL, Wood A, Smith N, Mistry R, Allen K, Jandial S, Tuckett JD, Gowdy SC, Foster HE, McErlane F, Hollingsworth KG.
Pediatr Rheumatol Online J. 2019 Nov 21;17(1):74. doi: 10.1186/s12969-019-0377-7.
PMID: 31752877 [PubMed - in process] Free PMC Article
Similar articles 

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL.
Rheumatology (Oxford). 2019 Feb 1;58(2):331-335. doi: 10.1093/rheumatology/key306.
PMID: 30358861 [PubMed - indexed for MEDLINE] Free PMC Article
Similar articles

No comments:

Post a Comment

Note: only a member of this blog may post a comment.